.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
Cerilliant
Johnson and Johnson
Fuji
AstraZeneca
Federal Trade Commission
UBS
Cantor Fitzgerald
Teva

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203510

« Back to Dashboard
NDA 203510 describes PHENYLEPHRINE HYDROCHLORIDE, which is a drug marketed by Paragon Bioteck, Akorn Inc, West Ward Pharm Corp, Vintage, and Hi-tech Pharmacal, and is included in five NDAs. It is available from five suppliers. There is one patent protecting this drug. Additional details are available on the PHENYLEPHRINE HYDROCHLORIDE profile page.

The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.

Summary for NDA: 203510

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 203510

Mechanism of ActionAdrenergic alpha1-Agonists

Suppliers and Packaging for NDA: 203510

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
SOLUTION/DROPS;OPHTHALMIC 203510 NDA Paragon BioTeck, Inc. 42702-102 42702-102-15 1 BOTTLE, DROPPER in 1 CARTON (42702-102-15) > 15 mL in 1 BOTTLE, DROPPER
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
SOLUTION/DROPS;OPHTHALMIC 203510 NDA Paragon BioTeck, Inc. 42702-103 42702-103-05 1 BOTTLE, DROPPER in 1 CARTON (42702-103-05) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength2.5%
Approval Date:Mar 21, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Nov 14, 2033Product Flag?Substance Flag?Delist Request?
Patented Use:DILATION OF THE PUPIL

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength10%
Approval Date:Mar 21, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Nov 14, 2033Product Flag?Substance Flag?Delist Request?
Patented Use:DILATION OF THE PUPIL


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
Mallinckrodt
Fish and Richardson
Citi
Chubb
Accenture
Harvard Business School
Teva
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot